tiprankstipranks
Trending News
More News >
Shield Therapeutics (GB:STX)
:STX
UK Market

Shield Therapeutics (STX) Technical Analysis

Compare
22 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
6Neutral
11Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Shield Therapeutics’s (STX) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Shield Therapeutics is a Sell.
Shield Therapeutics’s (STX) 20-Day exponential moving average is 2.50, while Shield Therapeutics’s (STX) share price is 2.5p, making it a Buy.
Shield Therapeutics’s (STX) 50-Day exponential moving average is 2.58, while Shield Therapeutics’s (STX) share price is 2.5p, making it a Sell.

Shield Therapeutics (STX) Pivot Points

Jun 14, 2025, 03:03 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.30
2.37
2.45
2.52
2.60
2.67
2.75
Fibonacci
2.37
2.43
2.47
2.52
2.58
2.62
2.67
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Shield Therapeutics (STX) Moving Averages

Jun 14, 2025, 03:03 PM
Period
Simple
Exponential
MA5
2.54Sell
2.52Sell
MA10
2.51Sell
2.51Sell
MA20
2.46Buy
2.50Buy
MA50
2.53Sell
2.58Sell
MA100
2.86Sell
2.72Sell
MA200
3.17Sell
2.89Sell
Shield Therapeutics’s (STX) 10-Day exponential moving average is 2.51, while Shield Therapeutics’s (STX) share price is 2.5p, making it a Sell.
Shield Therapeutics’s (STX) 100-Day exponential moving average is 2.72, while Shield Therapeutics’s (STX) share price is 2.5p, making it a Sell.
Shield Therapeutics’s (STX) stock price is 2.5p and Shield Therapeutics’s (STX) 50-day simple moving average is 2.53, creating a Sell signal.
Shield Therapeutics’s (STX) stock price is 2.5p and Shield Therapeutics’s (STX) 100-day simple moving average is 2.86, creating a Sell signal.
Shield Therapeutics’s (STX) stock price is 2.5p and Shield Therapeutics’s (STX) 200-day simple moving average is 3.17, creating a Sell signal.

Shield Therapeutics (STX) Technical Indicators

Jun 14, 2025, 03:03 PM
Name
Value
Implied Action
RSI (14)
49.40
Neutral
STOCH (9,6)
58.52
Neutral
STOCHRSI (14)
58.52
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
33.73
Neutral
Williams %R
-44.44
Buy
CCI (14)
60.12
Neutral
ATR (14)
0.20
-
Ultimate Oscillator
53.29
Neutral
ROC
2.04
Buy
Shield Therapeutics’s (STX) Relative Strength Index (RSI) is 49.40, creating a Neutral signal.
Shield Therapeutics’s (STX) Trend Strength Indicator (ADX) is 33.73, creating a Neutral signal.
Shield Therapeutics’s (STX) Commodity Channel Index (CCI) is 60.12, creating a Neutral signal.
Shield Therapeutics’s (STX) Price Rate of Change (ROC) is 2.04, creating a Buy signal.

FAQ

Is STX a Buy, Hold, or Sell?
Based on STX’s technical indicators, STX is a Sell.
    What is STX’s RSI (14)?
    STX’s RSI (14) is 49.40, which suggests STX is a Neutral.
      What is STX’s MACD?
      STX’s MACD is <0.01, which suggests STX is a Sell.
        What is STX’s 5-day moving average?
        STX’s 5-day moving average is 2.54, which suggests STX is a Sell.
          What is STX’s 20-day moving average?
          STX 20-day moving average is 2.46, which suggests STX is a Buy.
            What is STX’s 50-day moving average?
            STX’s 50-day moving average is 2.53, which suggests STX is a Sell.
              What is STX’s 200-day moving average?
              STX’s 200-day moving average is 3.17, which suggests STX is a Sell.
                What is STX’s Williams % R (14)?
                STX’s Williams % R (14) is -44.44, which suggests STX is a Buy.
                  What is STX’s CCI (14)?
                  STX’s CCI (14) is 60.12, which suggests STX is a Neutral.
                    What is the share price of Shield Therapeutics?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis